 | |
| Clinical data | |
|---|---|
| Other names | Thiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.016.600 |
| Chemical and physical data | |
| Formula | C10H16N2O2S |
| Molar mass | 228.31 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Thiobutabarbital (Inactin,Brevinarcon) is a short-actingbarbiturate derivative invented in the 1950s. It hassedative,anticonvulsant andhypnotic effects, and is still used inveterinary medicine for induction insurgicalanaesthesia.[1]
Thiobutabarbital contains a stereocenter and consists of two enantiomers. This is aracemate, i.e. a 1:1 mixture of (R)- and the (S)-form:[2]
| Enantiomers of Thiobutabarbital | |
|---|---|
-Thiobutabarbital_Structural_Formula_V1.svg) (R)-Form | -Thiobutabarbital_Structural_Formula_V1.svg) (S)-Form |
